Check-Cap Ltd (MBAI) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
No case yet. It builds on the next filing, report or 13F period.
Check-Cap Ltd has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 3844, X-Ray Apparatus & Tubes & Related Irradiation Apparatus, from each company's own filings. Largest first.
tall tick = annual report · 1 on record
No intraday reading yet this session.
Check-Cap Ltd
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
11 managers report a position worth $99,151 between them, and 3 of them hold 80% of it.
MBAI (Check-Cap Ltd) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.